We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts.
Legend Biotech Corporation (NASDAQ:LEGN) is among the best healthcare stocks
TheFly reported on June 3 that UBS increased its price target on LEGN to $49 from $31 while reiterating a Buy rating on the stock. The firm cited promising early clinical findings from the company’s LB5006 program, noting evidence of therapeutic activity at the higher dose level. UBS also highlighted the treatment’s favorable initial safety observations, which contributed to its positive outlook on the program’s development potential.
Moreover, on June 14, Legend Biotech Corporation (NASDAQ:LEGN) reported initial clinical proof-of-concept results for LB2501, an investigational in vivo CD19/CD20 dual-targeting CAR-T therapy for relapsed or refractory B-cell non-Hodgkin lymphoma. Data from an ongoing Phase 1 study showed that a single infusion produced dose-related CAR-T cell expansion without requiring lymphodepletion. At the higher dose level, the therapy delivered a 100% objective response rate and an 83.3% complete response rate, with all responses remaining active at the data cutoff date.